The anti-allergic drug histaglobin inhibits NF-κB nuclear translocation and down-regulates proinflammatory cytokines

doi:10.1016/S0192-0561(00)00037-0

International Journal of Immunopharmacology

Volume 22, Issue 10, October 2000, Pages 755-763

International Journa...

https://doi.org/10.1016/S0192-0561(00)00037-0 Get rights and content

Abstract

The transcription factor NF-κB is the central regulator for the expression of various genes involved in inflammation, infection and immune response including the genes for IL-1β, TNF-α, IL-6 and leukocyte adhesion molecules. Here, we show that the anti-allergic drug histaglobin down-regulates the release of IL-1β, TNF-α, IL-6 and IL-10 in human peripheral blood mononuclear cell cultures. This down-regulatory effect becomes even more pronounced when the cultures are simultaneously activated with the T-lymphocyte mitogen phytohemagglutinin (PHA) or with the B-lymphocyte and macrophage activator lipopeptide (P₃CSK₄). We also demonstrate that histaglobin inhibits the nuclear translocation of NF-κB in response to TNF-α or lipopolysaccharide (LPS) in bone marrow-derived macrophages of Balb/c mice. The inhibitory effect of histaglobin on NF-κB activation and cytokine release might be responsible for its anti-allergic effect as demonstrated in clinical studies.

Introduction

The anti-allergic drug histaglobin is used to treat allergic diseases such as bronchial asthma, allergic rhinitis and atopic dermatitis [1], [2], [3]. The drug was developed on the basis of the concept of histamine fixation to human serum [4]. Histaglobin has been reported to inhibit antigen-induced histamine release from human peripheral blood basophils and from rat peritoneal mast cells [5], [6], [7]. In addition, histaglobin has been shown to inhibit the allergen-induced peritoneal accumulation of eosinophils at inflammation sites [8]. The precise mechanism underlying the anti-allergic functions of histaglobin has yet to be investigated. In view of the important role that inflammatory cytokines and mediators play in regulating different types of allergy and asthma, we investigated the effect of histaglobin on IL-1β, TNF-α, IL-6 and IL-10 release from human peripheral blood mononuclear cell cultures. We also focused on the role of the transcription factor NF-κB because of its central involvement in mediating a wide variety of target genes that participate in inflammatory processes.

Section snippets

Reagents

Histaglobin was provided by Biobasal AG, Basel, Switzerland. The synthetic lipopeptide used in this study, N-palmitoyl-S-[2,3-bis(palmitoyloxy)-(R,S)-propyl]-(R)-cysteinyl-seryl-(lysyl)₃-lysine (P₃CSK₄), was obtained from ECHAZ microcollections, Tübingen, Germany. LPS from Salmonella abortus equi was kindly provided by C. Galanos (Max-Planck Institut für Immunbiologie, Freiburg, Germany). Recombinant mouse TNF-α was purchased from Pharmingen-Europe, Hamburg, Germany. Phytohemagglutinin (PHA)

Histaglobin inhibits the release of IL-1β, TNF-α, IL-6 and IL-10 from human peripheral blood mononuclear cells

The effect of histaglobin on IL-1β release was investigated using PBMCs. Treatment with histaglobin (75 and 300 μg/ml) for 72 h resulted in a marked reduction (p<0.001) of the constitutive IL-1β release into the medium in a dose-dependent manner (Fig. 1). Histaglobin also significantly (P<0.001) reduced the release of IL-1β from PBMCs activated with the T-lymphocyte mitogen PHA to the level of control cells treated with histaglobin alone.

In order to further characterize the inhibitory effect of

Discussion

In our study we looked for cellular targets involved in inflammatory reactions that could be potentially regulated by the anti-allergic drug histaglobin. We found that histaglobin down-regulates the release of the proinflammatory cytokines IL-1β and TNF-α from blood leukocytes (PBMC). These cytokines play a substantial role in the regulation of inflammatory responses: IL-1β and/or TNF-α have been shown to correlate with the induction of inflammatory mediators in smooth muscle cells, endometrial

Acknowledgements

We gratefully appreciate the excellent technical assistance of B. Erhard, B. Treyer and K. Vukovic. We thank Dr. K. Nübler-Jung for the critical review of this publication.

References (39)

H Yoshii et al.
A complex of histamine/mouse γ-globulin preferentially inhibits allergen-induced peritoneal accumlation of eosinophils, but not neutrophils, in mice
J. Allegy & Clinical Immunology
(1997)
F.A Meyer et al.
Differential effects of 1,25-(OH)₂D3 on acyl hydrolase and cyclooxygenase activities in IL-1β stimulated human synovial fibroblast cultures
Prostglandins Leukotrienes & Essential Fatty Acids
(1996)
C.A Dinarello
Interleukin-1 and interleukin-1 antagonism
Blood
(1991)
C.A Dinarello
Modalities for reducing interleukin activity in disease
Trends in Pharmacological Sciences
(1993)
A Eigler et al.
Taming TNF: strategies to restrain this proinflammatory cytokine
Immuno. Today
(1997)
Y Suzuki et al.
Significant increase of IL-6 production in blood mononuclear leukocytes obtained from patients with active inflammatory bowel disease
Life Sciences
(1990)
J.A Williams et al.
Regulation of macrophage cytokine production by prostaglandin E2. Distinct roles of cyclooxygenase-1 and -2
J. Biol. Chem.
(1997)
S Ito et al.
Interleukin-10 inhibits expression of both IFN-α- and IFN-γ-induced genes by suppressing tyrosine phosphorylation of STAT1
Blood
(1999)
M.A Stacey et al.
The allergen Der p1 induces NF-κB activation through interference with IκB-α function in asthmatic bronchial epithelial cells
Biochem. Biophys. Res. Commun.
(1997)
J Liebhart et al.
Changes of histaminopexy in patients with bronchial asthma and chronic urticaria after histaglobin administration
Archivum Immunologiae et Therapiae Experimentalis
(1986)

I.S Gushchin et al.

Therapeutic effectiveness of histaglobin preparations in patients with allergic rhinitis and chronic urticaria

Terapevticheskii Arkhiv

(1999)

A Paci et al.

Therapy of atopic dermatitis in childern. Study on the use of a desensitizing preparation

Pediatria Medicae Chirurgica

(1986)

J.L Parrot et al.

The histamine-fixing power of blood serum. Its modification after an injection of human serum or azoprotein of histamine

J. Physiol.

(1951)

A Ohnishi et al.

Inhibitory effect of histamine-added human gammaglobulin on histamine release from human leucocytes

Clin. Immunol.

(1985)

T Ishikawa et al.

Inhibition of rat mast cell degranulation and histamine release by histamine-rat gamma-globulin conjugate

International Archives of Allergy and Applied Immunology

(1979)

K Watanabe et al.

Inhibitory effect of histamine-carried rat gamma globulin on histamine release from rat mast cells

Arerugi.

(1979)

P Hoffmann et al.

Induction of tumor cytotoxicity in murine bone-marrrow-derived macrophages by two synthetic lipopeptide analogues

Biol. Chem. Hopper-Seyler

(1989)

F Beranger et al.

The effector domain of Rab6 plus a highly hydrophobic C terminus, is required for Golgi apparatus localization

Mol. Cell. Biol.

(1994)

I Pons et al.

Consequences of gamma-irradiation on inflammatory cytokine regulation in human monocytes/macrophages

International Journal of Radiation Biology

(1997)

Cited by (13)

Allyl methyl disulfide inhibits IL-8 and IP-10 secretion in intestinal epithelial cells via the NF-kB signaling pathway
2015, International Immunopharmacology
Citation Excerpt :
NF-кB exists as an inactive complex (p50 ± p65/IкB) in the cytoplasm of most resting cells, where it is bound to its inhibitory protein IкB, which is phosphorylated by a cellular kinase complex known as IKK (26). The translocation of NF-кB into the nucleus is associated with the transcription of various pro-inflammatory factors, such as IL-8 [48]. To identify the transcription factors that are activated by TNF-α stimulation, the DNA-binding activity of NF-кB was measured using immunocytochemistry.
Garlic and its active constituents have shown versatile medicinal activities in the prevention and treatment of various disorders. Allyl methyl disulfide (AMDS) was identified as one of the major bioactive components in an effective inhalation fork remedy using fresh garlic paste in our previous study. In this work, we investigated the immunological properties of AMDS to elucidate the underlying mechanisms of the fork inhalation treatment using fresh garlic. The inhibition effect of AMDS on TNF-α-induced IL-8 and IP-10 production in intestinal epithelial cell lines HT-29 and Caco-2 was first evaluated. Pretreatment of the cells with AMDS attenuated IL-8 and IP-10 secretion induced by TNF-α in a dose-dependent manner in the non-cytotoxic concentration range of 20 to 150 μM. Mechanistic studies revealed that AMDS suppressed the accumulation of IL-8 mRNA and inhibited IкBα degradation and NF-кB p65 translocation into the nucleus at both the transcriptional and translational levels, suggesting that the attenuation effort of AMDS on cytokine IL-8 secretion might at least be partially related to the NF-κB signaling pathway. These results suggest that AMDS may be a promising phytochemical agent in the treatment of immunological disorders, such as ulcerative colitis, Crohn's disease, intestinal inflammatory diseases and others. In addition, the mechanistic study data indicated that immune modulation could be one of the therapeutic mechanisms of the effective fork treatment containing AMDS as one of the major components.
Atopy: New targets and new therapies
2006, Veterinary Clinics of North America - Small Animal Practice
Citation Excerpt :
Other antiallergic compounds that have been used in human medicine for nonspecific immunotherapy include histaglobin and neutropin. Histaglobin has been reported to downregulate the release of IL-1β, TNFα, IL-6, and IL-10 in human peripheral blood mononuclear cell cultures [62] and to decrease or resolve symptoms of AD and rhinitis [63,64]. So far, no studies have been conducted in dogs to evaluate the efficacy of this therapy.
Substance P induces TNF-α and IL-6 production through NFκB in peritoneal mast cells
2003, Biochimica et Biophysica Acta - Molecular Cell Research
The neuropeptide Substance P (SP) is an important mediator of neuroimmunomodulatory activity. The aim of this study is to elucidate the mechanism used by SP to promote increased production of pro-inflammatory cytokines in fresh isolated rat peritoneal mast cells (rPMC). We have demonstrated that SP induces production of interleukin-6 (IL-6) in rPMC through the PI-3K, p42/44 and p38 MAP kinase pathways. SP-stimulated rPMC also exhibited an enhanced nuclear translocation of the nuclear factor κ B (NFκB). The tumour necrosis factor-α (TNF-α) and IL-6 production was completely inhibited by using (E)-4-hydroxynonenal (HNE) as an inhibitor of IκB-α and -β phosphorylation. Further, TNF-α and IL-6 expression was significantly inhibited by the oligonucleotides (ODNs) containing the NFκB element (NFκB decoy ODNs) but not by the scrambled control ODNs. These findings indicate that the NFκB pathway is involved in the transcriptional regulation of the TNF-α and IL-6 overexpression in primary SP-stimulated mast cells.
Modulation of the Th1/Th2 bias by an immunoglobulin histamine complex in the ovalbumin allergy mouse model
2003, International Immunopharmacology
Vaccination with the antiallergic drug Histaglobin is used to treat a broad range of human allergic diseases including bronchial asthma, allergic rhinitis, and atopic dermatitis. In order to further elucidate its functional activity, Histaglobin was investigated in an in vivo mouse allergy model. Mice were sensitized with ovalbumin either prior to or after Histaglobin treatment, and its antiallergic potential was evaluated. Ovalbumin-sensitized mice exhibited increased serum levels of IL-4, tumor necrosis factor alpha (TNF-α), and an increase of total and ovalbumin-specific IgE; total and ovalbumin-specific IgG levels were also elevated. Subsequent administration (therapeutic treatment) of Histaglobin resulted in a decrease of total and specific serum IgE levels; total and specific IgG1 serum levels were reduced by more than 50% and 45%, respectively; the mice displayed a down-regulation of IL-4 and TNF-α serum levels and showed increased levels of IFN-γ and IgG2a. Mice pretreated with Histaglobin, prior to ovalbumin sensitization (prophylactic treatment), were found to be widely unresponsive to ovalbumin. They exhibited higher serum levels of IFN-γ and IgG2a (total and specific) compared to saline-treated control mice. The inhibitory effects were still observed 1 month post-immunization.
Our data, indicating a Histaglobin-induced modulation of the Th1/Th2 balance in favour of Th1, correspond with the well-known antiallergic activity of Histaglobin observed in patients.
Human keratinocytes express functional CD14 and toll-like receptor 4
2002, Journal of Investigative Dermatology
Citation Excerpt :
From the ratio of measured fluorescence at the two excitation wavelengths, the intracellular free calcium was calculated as previously described (Roe et al, 1990). Indirect immunofluorescence analyses for NF-κB localization were performed as previously described (Ayoub et al, 2000;Dikov et al, 2001). Human keratinocytes were seeded at a concentration of 104-105 cells per well into chamber slides (154526, Nalgen Nunc International) and allowed to grow to about 70% confluence.
CD14 and the toll-like receptor 4 have been known to play an important role in lipopolysaccharide-induced cellular responses in bacterial infections. Although CD14 and toll-like receptor 4 expression has been demonstrated in a number of myeloid cells, much less is known about the expression and function of these lipopolysaccharide receptors on nonleukocytes. In this study, we demonstrate that human keratinocytes are capable of expressing functional CD14 and toll-like receptor 4. Keratinocytes were found to constitutively express CD14 and toll-like receptor 4 mRNA that was augmented by exposure to lipopolysaccharide. Cell surface expression of keratinocyte CD14 and toll-like receptor 4 was detected by flow cytometry. Lipopolysaccharide binding to keratinocyte CD14 and toll-like receptor 4 resulted in a rapid intracellular Ca²⁺ response, nuclear factor-κB nuclear translocation, and the secretion of proinflammatory cytokines and chemokines. These results have important implications for our understanding of cutaneous innate immunity to bacterial infections of the skin.
Induction of remission in chronic urticaria by immunotherapy using immunoglobulin/histamine complex (Histobulin™): a case report
2021, Allergy, Asthma and Clinical Immunology

View all citing articles on Scopus

View full text